Article, big buy-outs in biotech. We knew about th
Post# of 72434
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
http://www.fiercepharma.com/pharma-asia/fierc...oifQ%3D%3D
So if that non-standard treatment is worth 819 million, what would be the value of a treatment by a first-line drug for a more common disease, like psoriasis?
(rhetorical question)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)